We found a match
Your institution may have rights to this item. Sign in to continue.
- Title
MHC class I-presented tumor antigen appraisable for T-cell responses against ovarian cancer.
- Authors
Jing Yao Wang; Nan Zhang; Xiaojie Yang; Danli Gao; Lirong Yin; Shuying Ji
- Abstract
The purpose of this study is to assess whether MHC class I-presented tumor antigen is appraisable for T-cell responses against ovarian cancer. In ovarian cancer cell, human leukocyte antigen A2 (HLA-A2) associated with peptides was used to promote the activation of naive T cells so as to activate antigen-specific T cells. 7 or 4 patients were observed grade 1 or 2 injection site reactions, respectively. 5, 2 or 1 patients were observed grade 1, 2 or 3 pain reactions, respectively. 4 or 1 patients were observed grade 1 or 2 induration reactions. Total number mean value of patients experiencing response to the particular peptide was 7.73, and total number mean value of peptides to which the patients responded was 7.45. MHC class I-presented tumor antigen is appraisable for T-cell responses against ovarian cancer in China.
- Subjects
TUMOR antigens; IMMUNITY; LYMPHOCYTES; TUMOR markers; ONCOLOGY
- Publication
Bangladesh Journal of Pharmacology, 2015, Vol 10, Issue 3, p524
- ISSN
1991-007X
- Publication type
Article
- DOI
10.3329/bjp.v10i3.23076